9 Oct 2018 08:01
9 October 2018
MedaPhor Group plc
(the "Group", or the "Company")
Director/PDMR Shareholding
Further to the announcement made on 8 October 2018, MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that Andrew Barker, Non-Executive Director of the Company, has been issued 66,781 new ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to the completion of the acquisition of Intelligent Ultrasound Limited, which was originally announced on 19 September 2017.
Following this issue, Mr. Barker has an interest in 200,344 Ordinary Shares representing approximately 0.2 per cent. of the Company's issued ordinary share capital.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Andrew Barker | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-Executive Director | ||||
b)
| Initial notification /Amendment
| Initial | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| MEDAPHOR GROUP PLC | ||||
b)
| LEI
| 213800K4ZVWL4ZYQAZ70 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 1 pence each
ISIN: GB00BN791Q39
| ||||
b)
| Nature of the transaction
| Issue of new Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggregated volume
- Price
|
N/A - single transaction
| ||||
e)
| Date of the transaction
| 9 October 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange, XLON | ||||
Enquiries:
MedaPhor Group plc | www.medaphor.com | |
Stuart Gall, CEO | Tel: +44 (0)29 2075 6534 | |
Cenkos Securities | Tel: +44 (0)20 7397 8900 | |
Mark Connelly (Nominated Advisor) | ||
Michael Johnson / Julian Morse (Corporate Broking) | ||
Walbrook PR | Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com | |
Paul McManus / Anna Dunphy | Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001 | |